Key Takeaways
- AstraZeneca (AZN) and Bristol Myers Squibb (BMY) are reportedly in preliminary merger talks for a deal that could be valued at nearly $400 billion, potentially creating the world's fourth-largest drugmaker.
- Bristol Myers Squibb (BMY) shares rose 3.8% in premarket trading following the reports, while AstraZeneca's London-listed shares fell over 7% on concerns regarding regulatory hurdles and deal execution.
- Mitsubishi Electric (6503.T) expects to restore full operations at its Kumamoto power semiconductor plants by August, following a magnitude 7.1 earthquake that disrupted the region's "Silicon Valley."
- Citi placed Applied Materials (AMAT) on a 30-day "Upside Catalyst Watch," citing a positive outlook for NAND equipment demand and a projected $145 billion wafer fabrication equipment market in 2026.
Pharma Giants Explore $400 Billion Megamerger
Reports surfaced on Sunday that UK-based pharmaceutical giant AstraZeneca (AZN) has held preliminary discussions to acquire its U.S. rival Bristol Myers Squibb (BMY). The potential combination would create a healthcare powerhouse with a market valuation approaching $400 billion. While talks have reportedly been ongoing for several months, sources cautioned that a deal is not certain and could still fall apart.
The news sent Bristol Myers Squibb (BMY) shares climbing 3.8% in premarket trading on Monday. Conversely, AstraZeneca (AZN) saw its shares plunge more than 7% in London as investors weighed the massive scale of the acquisition and the significant overlap in the companies' oncology portfolios. Analysts noted that any formal agreement would likely face intense scrutiny from antitrust regulators in both the U.S. and Europe.
Japan’s Chip Hub Targets August Recovery
Mitsubishi Electric (6503.T) announced that it aims to restore full production capacity at its Kumamoto semiconductor facilities within the month of August. The plants, which manufacture critical power semiconductors, were partially idled following a powerful earthquake in late July. The company has already begun resuming cleanroom operations and is currently performing precision recalibrations on manufacturing equipment.
The recovery in Kumamoto is being closely watched by the global electronics and automotive sectors. Other major players in the region, including Sony (SONY) and Renesas Electronics (6723.T), have also signaled a phased return to normal operations by mid-August. Despite the disruptions, industry experts suggest that enhanced disaster-prevention measures implemented after the 2016 quake have significantly mitigated structural damage this time.
Applied Materials Gains "Catalyst Watch" Status at Citi
Citi analysts have initiated a 30-day "Upside Catalyst Watch" on Applied Materials (AMAT), expressing bullishness ahead of the company's upcoming financial disclosures. The bank pointed to a strengthening recovery in NAND flash memory spending and resilient demand for AI-related semiconductor infrastructure. Citi maintains a positive outlook on the broader wafer fabrication equipment (WFE) market, which it estimates will grow to $145 billion this year.
The designation suggests that Citi expects near-term news or earnings data to drive the stock price higher. Applied Materials (AMAT) continues to benefit from its dominant position in providing tools for advanced logic and memory chips. The firm’s role in supporting the expansion of global foundry capacity, including new projects in Japan and the U.S., remains a central pillar of its long-term growth thesis.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.